Drugs / Beta Glucosylceramide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02126306 Comparator | Jan 2006 → Dec 2010 | — | Hadassah Medical Organization | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Beta Glucosylceramide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02126306 ↗ |
| Route | Oral | “Beta glucosylceramide administered orally daily” NCT02126306 ↗ |